Sonya Abraham

2.1k total citations
44 papers, 1.5k citations indexed

About

Sonya Abraham is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Sonya Abraham has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 14 papers in Immunology and 10 papers in Hematology. Recurrent topics in Sonya Abraham's work include Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Psoriasis: Treatment and Pathogenesis (10 papers). Sonya Abraham is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Psoriasis: Treatment and Pathogenesis (10 papers). Sonya Abraham collaborates with scholars based in United Kingdom, United States and Denmark. Sonya Abraham's co-authors include Andrew R. Clark, Jeremy Saklatvala, Marina Lasa, Jan Tuckermann, Anna Kleiman, Toby Lawrence, Hannah Jethwa, Peter C. Taylor, Ejaz Pathan and Richard Williams and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Molecular and Cellular Biology.

In The Last Decade

Sonya Abraham

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonya Abraham United Kingdom 15 599 484 335 263 166 44 1.5k
Aleksander M. Grabiec Poland 24 584 1.0× 906 1.9× 247 0.7× 281 1.1× 181 1.1× 47 1.8k
Lidan Zhao China 23 712 1.2× 536 1.1× 741 2.2× 156 0.6× 116 0.7× 85 1.9k
Sujata Sarkar United States 14 1.0k 1.7× 253 0.5× 309 0.9× 279 1.1× 81 0.5× 21 1.6k
Diego Catalán Chile 22 941 1.6× 468 1.0× 314 0.9× 220 0.8× 49 0.3× 42 1.7k
Carla Guthridge United States 10 511 0.9× 302 0.6× 197 0.6× 168 0.6× 85 0.5× 19 1.1k
Catherine Maari Canada 27 887 1.5× 347 0.7× 363 1.1× 206 0.8× 139 0.8× 65 2.4k
Yoshinori Komagata Japan 20 857 1.4× 238 0.5× 244 0.7× 216 0.8× 69 0.4× 60 1.6k
TA Luger Germany 26 757 1.3× 323 0.7× 321 1.0× 183 0.7× 76 0.5× 68 2.0k
Mir‐Farzin Mashreghi Germany 26 1.2k 2.1× 639 1.3× 223 0.7× 314 1.2× 264 1.6× 84 2.3k
Lauren J. Lahey United States 28 723 1.2× 631 1.3× 1.3k 3.9× 189 0.7× 132 0.8× 37 2.5k

Countries citing papers authored by Sonya Abraham

Since Specialization
Citations

This map shows the geographic impact of Sonya Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonya Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonya Abraham more than expected).

Fields of papers citing papers by Sonya Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonya Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonya Abraham. The network helps show where Sonya Abraham may publish in the future.

Co-authorship network of co-authors of Sonya Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Sonya Abraham. A scholar is included among the top collaborators of Sonya Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonya Abraham. Sonya Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abraham, Sonya, Davide Carone, Orell Mielke, et al.. (2025). Automatically quantified follow-up imaging biomarkers predict clinical outcomes after acute ischemic stroke. Frontiers in Neurology. 16. 1483138–1483138.
2.
Coto‐Segura, Pablo, Antonio Martorell, D. Moreno‐Ramírez, et al.. (2023). A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis. Frontiers in Immunology. 14. 1212981–1212981. 4 indexed citations
3.
Gardiner, Tom A., et al.. (2021). Racial and ethnic health disparities in healthcare settings. BMJ. 372. n605–n605. 6 indexed citations
4.
Jethwa, Hannah & Sonya Abraham. (2021). Training the trainees: COVID-19 and rheumatologists of the future. Clinical Medicine. 21(1). e94–e95. 2 indexed citations
5.
Blanco, Jesús Miguéns, Federica Borghese, Neil McHugh, et al.. (2020). Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study. BMC Rheumatology. 4(1). 60–60. 2 indexed citations
6.
Coates, Laura C., Sonya Abraham, William Tillett, et al.. (2020). Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab. Arthritis Care & Research. 74(2). 259–267. 4 indexed citations
7.
Jethwa, Hannah, Ann M. Sullivan, & Sonya Abraham. (2020). COVID-19 and Immunomodulatory Therapy — Can We Use Data from Previous Viral Pandemics?. The Journal of Rheumatology. 47(12). 1734–1737. 3 indexed citations
8.
Searle, Graham E., et al.. (2020). Specificity of translocator protein-targeted positron emission tomography in inflammatory joint disease. EJNMMI Research. 10(1). 147–147. 7 indexed citations
9.
Aggarwal, Dinesh, et al.. (2018). The use of biomarkers as a tool for novel psoriatic disease drug discovery. Expert Opinion on Drug Discovery. 13(9). 875–887. 5 indexed citations
10.
Lim, Adrian, et al.. (2017). Microflow imaging: New Doppler technology to detect low-grade inflammation in patients with arthritis. European Radiology. 28(3). 1046–1053. 53 indexed citations
11.
Cooksley, Helen, et al.. (2016). Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 303–303. 29 indexed citations
12.
Liu, Nathan, et al.. (2016). Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis. Nanoscale. 8(8). 4482–4485. 19 indexed citations
14.
Khanna, Monica, et al.. (2014). A painful swollen thigh in a diabetic patient: diabetic myonecrosis. The Lancet. 383(9931). 1860–1860. 2 indexed citations
15.
Alzabin, Saba, Sonya Abraham, Taher E. Taher, et al.. (2012). Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway. Annals of the Rheumatic Diseases. 71(10). 1741–1748. 122 indexed citations
16.
Pathan, Ejaz, Sonya Abraham, R H Withrington, et al.. (2012). Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Annals of the Rheumatic Diseases. 72(9). 1475–1480. 98 indexed citations
17.
Abraham, Sonya, et al.. (2012). Dual‐specificity phosphatase 1–null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis & Rheumatism. 64(7). 2201–2210. 32 indexed citations
18.
Mehta, Puja, et al.. (2011). Normal in the blood, abnormal in the urine. QJM. 105(10). 1001–1002. 2 indexed citations
20.
Abraham, Sonya, et al.. (2009). Sinonasal sarcoid. Journal of Postgraduate Medicine. 55(1). 43–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026